Arsenic trioxide induced apoptosis in retinoblastoma cells by abnormal expression of microRNA-376a

Neoplasma

Volumn 60, Issue 3, 2013, Pages 247-253

  Zhang, Y ^a,b   Wu, J H ^c   Han, F ^d   Huang, J M ^e   Shi, S Y ^f   Gu, R D ^a   Chen, X L ^a   He, B ^c,g  

^a CHINA MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d CHENGDU MILITARY GENERAL HOSPITAL   (China)

^e No 85 Hospital of PLA   (China)

^f 230 Hospital of People's Liberation Army   (China)

^g SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Arsenic trioxide; MicroRNA; Retinoblastoma

Indexed keywords

ARSENIC TRIOXIDE; CASPASE 3; MICRORNA; MICRORNA 376 A; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; LUCIFERASE; MESSENGER RNA; MIRN376 MICRORNA, HUMAN; ORGANOARSENIC DERIVATIVE; OXIDE; TUMOR MARKER;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE COMPARISON; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MICROARRAY ANALYSIS; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL PROLIFERATION; DNA MICROARRAY; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; BLOTTING, WESTERN; CASPASE 3; CELL PROLIFERATION; HUMANS; LUCIFERASES; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDES; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84879394136     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_033     Document Type: Article

References (21)

1. N.A. LAURIE, C.S. SHIH, M.A. DYER, Targeting MDM2 and MDMX in retinoblastoma. Curr Cancer Drug Targets 7 (2007) 689-695. http://dx.doi.org/10.2174/156800907782418266
2. E. LENGFELDER, W.K. HOFMANN, D. NOWAK, Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia 26 (2012) 433-442. http://dx.doi.org/10.1038/leu.2011.245
3. F. BINET, F. ANTOINE, D. GIRARD, Interaction between arsenic trioxide and human primary cells: emphasis on human cells of myeloid origin. Inflamm Allergy Drug Targets 8 (2009) 21-27. http://dx.doi.org/10.2174/187152809787582516
4. I. ORA, L. BONDESSON, C. JONSSON, J. LJUNGBERG, I. PORN-ARES, et al. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro. Biochem Biophys Res Commun 277 (2000) 179-185.
5. L.E. BECKER, D. HINTON, Primitive neuroectodermal tumors of the central nervous system. Hum Pathol 14 (1983) 538-550. http://dx.doi.org/10.1016/S0046-8177(83)80006-9
6. M.A. DYER, Mouse models of childhood cancer of the nervous system. J Clin Pathol 57 (2004) 561-576. http://dx.doi.org/10.1136/jcp.2003.009910
7. J.H. KIM, Y.S. YU, D.H. KIM, C.J. KIM, K.W. KIM, Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration. Invest Ophthalmol Vis Sci 50 (2009) 1819-1823.
8. A. ESQUELA-KERSCHER, F.J. SLACK, Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6 (2006) 259-269. http://dx.doi.org/10.1038/nrc1840
9. O.A. KENT, J.T. MENDELL, A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25 (2006) 6188-6196. http://dx.doi.org/10.1038/sj.onc.1209913
10. J.C. HUANG, T. BABAK, T.W. CORSON, G. CHUA, S. KHAN et al. Using expression profiling data to identify human microRNA targets. Nat Methods 4 (2007) 1045-1049.
11. S.J. MARTIN, C.P. REUTELINGSPERGER, A.J. MCGAHON, J.A. RADER, R.C. VAN SCHIE, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182 (1995) 1545-1556. http://dx.doi.org/10.1084/jem.182.5.1545
12. I. VERMES, C. HAANEN, H. STEFFENS-NAKKEN, C. REUTELINGSPERGER, A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184 (1995) 39-51. http://dx.doi.org/10.1016/0022-1759(95)00072-I
13. D.E. FISHER, Apoptosis in cancer therapy: crossing the threshold. Cell 78 (1994) 539-542. http://dx.doi.org/10.1016/0092-8674(94)90518-5
14. G.M. COHEN, CASPASES: the executioners of apoptosis. Biochem J 326 (Pt 1) (1997) 1-16.
15. B.G. CAMPLING, J. PYM, P.R. GALBRAITH, S.P. COLE, Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk Res 12 (1988) 823-831. http://dx.doi.org/10.1016/0145-2126(88)90036-7
16. D.P. BARTEL, MicroRNAs: target recognition and regulatory functions. Cell 136 (2009) 215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002
17. D.P. BARTEL, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5
18. R.C. FRIEDMAN, K.K. FARH, C.B. BURGE, D.P. BARTEL, Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19 (2009) 92-105. http://dx.doi.org/10.1101/gr.082701.108
19. Q. DONG, P. MENG, T. WANG, W. QIN, F. WANG, et al. MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS One 5 (2010) e10147. http://dx.doi.org/10.1371/journal.pone.0010147
20. R.S. PILLAI, S.N. BHATTACHARYYA, W. FILIPOWICZ, Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17 (2007) 118-126. http://dx.doi.org/10.1016/j.tcb.2006.12.007
21. Z. SU, J. XIA, Z. ZHAO, Functional complementation between transcriptional methylation regulation and post-transcriptional microRNA regulation in the human genome. BMC Genomics 12 Suppl 5 (2011) S15. http://dx.doi.org/10.1186/1471-2164-12-S5-S15